177 related articles for article (PubMed ID: 30170702)
1. Pleural malignant mesothelioma versus pleuropulmonary synovial sarcoma: a clinicopathological study of 22 cases with molecular analysis and survival data.
Klebe S; Prabhakaran S; Hocking A; Pulford E; Moore S; Nicola M; Allen PW; Henderson DW
Pathology; 2018 Oct; 50(6):629-634. PubMed ID: 30170702
[TBL] [Abstract][Full Text] [Related]
2. SYT-SSX fusion is absent in sarcomatoid mesothelioma allowing its distinction from synovial sarcoma of the pleura.
Weinbreck N; Vignaud JM; Begueret H; Burke L; Benhattar J; Guillou L; Capron F; Galateau-Salle F
Mod Pathol; 2007 Jun; 20(6):617-21. PubMed ID: 17507990
[TBL] [Abstract][Full Text] [Related]
3. Challenges and controversies in the diagnosis of malignant mesothelioma: Part 2. Malignant mesothelioma subtypes, pleural synovial sarcoma, molecular and prognostic aspects of mesothelioma, BAP1, aquaporin-1 and microRNA.
Henderson DW; Reid G; Kao SC; van Zandwijk N; Klebe S
J Clin Pathol; 2013 Oct; 66(10):854-61. PubMed ID: 23833051
[TBL] [Abstract][Full Text] [Related]
4. TLE1 expression in malignant mesothelioma.
Matsuyama A; Hisaoka M; Iwasaki M; Iwashita M; Hisanaga S; Hashimoto H
Virchows Arch; 2010 Nov; 457(5):577-83. PubMed ID: 20857142
[TBL] [Abstract][Full Text] [Related]
5. Cystic synovial sarcoma of the pleura mimicking a cystic thymoma: a case report illustrating the role of decreased INI-1 expression in differential diagnosis.
Tajima S; Takahashi T; Itaya T; Koda K; Neyatani H
Int J Clin Exp Pathol; 2015; 8(3):3262-9. PubMed ID: 26045850
[TBL] [Abstract][Full Text] [Related]
6. Primary monophasic synovial sarcoma of the pleura: five cases confirmed by the presence of SYT-SSX fusion transcript.
Aubry MC; Bridge JA; Wickert R; Tazelaar HD
Am J Surg Pathol; 2001 Jun; 25(6):776-81. PubMed ID: 11395555
[TBL] [Abstract][Full Text] [Related]
7. Transducer-like enhancer of split 1 (TLE1) expression as a diagnostic immunohistochemical marker for synovial sarcoma and its association with morphological features.
Bakrin IH; Hussain FA; Tuan Sharif SE
Malays J Pathol; 2016 Aug; 38(2):117-22. PubMed ID: 27568668
[TBL] [Abstract][Full Text] [Related]
8. Synovial sarcoma and malignant mesothelioma of the pleura: review, differential diagnosis and possible role of apoptosis.
Cappello F; Barnes L
Pathology; 2001 May; 33(2):142-8. PubMed ID: 11358044
[TBL] [Abstract][Full Text] [Related]
9. Value of D2-40 in the differential diagnosis of pleural neoplasms with emphasis on its positivity in solitary fibrous tumor.
Hu Y; Yang Q; McMahon LA; Wang HL; Xu H
Appl Immunohistochem Mol Morphol; 2010 Oct; 18(5):411-3. PubMed ID: 20436345
[TBL] [Abstract][Full Text] [Related]
10. Whole-exome sequencing in primary pulmonary synovial sarcoma misdiagnosed as mesothelioma: A case report and literature review.
Wu D; Zhang H; Li X; Liu J; Liu M; Liu H; Dong M; Chen J
Thorac Cancer; 2023 Jun; 14(16):1520-1529. PubMed ID: 37089080
[TBL] [Abstract][Full Text] [Related]
11. Specificity of TLE1 expression in unclassified high-grade sarcomas for the diagnosis of synovial sarcoma.
Valente AL; Tull J; Zhang S
Appl Immunohistochem Mol Morphol; 2013 Oct; 21(5):408-13. PubMed ID: 23197007
[TBL] [Abstract][Full Text] [Related]
12. Immunohistochemical validation of TLE1, a novel marker, for synovial sarcomas.
Rekhi B; Basak R; Desai SB; Jambhekar NA
Indian J Med Res; 2012 Nov; 136(5):766-75. PubMed ID: 23287123
[TBL] [Abstract][Full Text] [Related]
13. Molecular analyses, morphology and immunohistochemistry together differentiate pleural synovial sarcomas from mesotheliomas: clinical implications.
Carbone M; Rizzo P; Powers A; Bocchetta M; Fresco R; Krausz T
Anticancer Res; 2002; 22(6B):3443-8. PubMed ID: 12552937
[TBL] [Abstract][Full Text] [Related]
14. Detection of the SYT-SSX fusion transcripts in formaldehyde-fixed, paraffin-embedded tissue: a reverse transcription polymerase chain reaction amplification assay useful in the diagnosis of synovial sarcoma.
Lasota J; Jasinski M; Debiec-Rychter M; Szadowska A; Limon J; Miettinen M
Mod Pathol; 1998 Jul; 11(7):626-33. PubMed ID: 9688183
[TBL] [Abstract][Full Text] [Related]
15. Monoclonal Caveolin 1 Expression in the Differential Diagnosis of Malignant Pleural Mesothelioma and Pulmonary Adenocarcinoma: Is it Useful?
Bozdag Z; Tutar E; Dizibuyuk OF; Bakir K
Pathol Oncol Res; 2020 Jul; 26(3):1651-1656. PubMed ID: 31512057
[TBL] [Abstract][Full Text] [Related]
16. Transducer-like Enhancer of Split 1 as a Novel Immuno- histochemical Marker for Diagnosis of Synovial Sarcoma.
Atef A; Alrashidy M
Asian Pac J Cancer Prev; 2015; 16(15):6545-8. PubMed ID: 26434872
[TBL] [Abstract][Full Text] [Related]
17. Primary pulmonary synovial sarcoma confirmed by molecular detection of SYT-SSX1 fusion gene transcripts: a case report and review of the literature.
Hosono T; Hironaka M; Kobayashi A; Yamasawa H; Bando M; Ohno S; Sohara Y; Sugiyama Y
Jpn J Clin Oncol; 2005 May; 35(5):274-9. PubMed ID: 15879502
[TBL] [Abstract][Full Text] [Related]
18. Calretinin and other mesothelioma markers in synovial sarcoma: analysis of antigenic similarities and differences with malignant mesothelioma.
Miettinen M; Limon J; Niezabitowski A; Lasota J
Am J Surg Pathol; 2001 May; 25(5):610-7. PubMed ID: 11342772
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic usefulness of p16/CDKN2A FISH in distinguishing between sarcomatoid mesothelioma and fibrous pleuritis.
Wu D; Hiroshima K; Matsumoto S; Nabeshima K; Yusa T; Ozaki D; Fujino M; Yamakawa H; Nakatani Y; Tada Y; Shimada H; Tagawa M
Am J Clin Pathol; 2013 Jan; 139(1):39-46. PubMed ID: 23270897
[TBL] [Abstract][Full Text] [Related]
20. Pleural neoplastic pathology.
Karpathiou G; Stefanou D; Froudarakis ME
Respir Med; 2015 Aug; 109(8):931-43. PubMed ID: 26048082
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
